ask="2.84"
ask_size="400"
average_daily_volume="850790"
bid="2.57"
bid_size="100"
book_value="0.34"
change="+0.28"
change_from_200_day_moving_average="1.13"
change_from_50_day_moving_average="1.11"
change_from_52_week_high="-2.29"
change_From_52_week_low="1.70"
change_in_percent="+11.07%"
close="2.81"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-1.58"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-0.88"
ex_dividend_date="N/A"
float_shares="4192000"
high="3.17"
high_52_weeks="5.10"
last_trade_date="2/23/2017"
last_trade_price="2.81"
last_trade_size="5537"
last_trade_time="4:00pm"
low="2.54"
low_52_weeks="1.11"
market_capitalization="26.93M"
moving_average_200_day="1.68"
moving_average_50_day="1.70"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.00"
open="2.80"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+67.72%"
percent_change_from_50_day_moving_average="+65.17%"
percent_change_from_52_week_high="-44.90%"
percent_change_from_52_week_low="+153.15%"
previous_close="2.53"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.46"
price_per_sales="47.65"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="0.76"
stock_exchange="NCM"
symbol="EYEG"
volume="5754225"
weeks_range_52="1.11 - 5.10"
